Isosorbide mononitrate and Autoimmune thrombocytopenia - a phase IV clinical study of FDA data


No or too few reports are found.

The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.

On Sep, 25, 2023

No or too few reports are found.

What is Isosorbide Mononitrate?

Isosorbide mononitrate has active ingredients of isosorbide mononitrate. It is used in angina. Currently, eHealthMe is studying from 25,447 Isosorbide mononitrate users.

What is Autoimmune Thrombocytopenia?

Autoimmune thrombocytopenia (isolated low platelet count (thrombocytopenia) with normal bone marrow and the absence of other causes of thrombocytopenia) is found to be associated with 515 drugs and 317 conditions by eHealthMe. Currently, we are studying 987 people who have Autoimmune thrombocytopenia.

Do you take Isosorbide mononitrate and have Autoimmune thrombocytopenia?

Check whether Autoimmune thrombocytopenia is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Autoimmune thrombocytopenia and when was it recovered:

Expand to all the drugs that have ingredients of isosorbide mononitrate:

Alternative drugs to, pros and cons of Isosorbide mononitrate:

Browse all side effects of Isosorbide mononitrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Autoimmune thrombocytopenia treatments and more:

All the drugs that are associated with Autoimmune thrombocytopenia:

All the conditions that are associated with Autoimmune thrombocytopenia:

How the study uses the data?

The study uses data from the FDA. It is based on isosorbide mononitrate (the active ingredients of Isosorbide mononitrate) and Isosorbide mononitrate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: